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Abstract
With the successful clinical trials, multifunctional glycoprotein bovine lactoferrin is gaining attention as a safe nutraceutical
and biologic drug targeting cancer, chronic-inflammatory, viral and microbial diseases. Interestingly, recent findings that
human lactoferrin oligomerizes under simulated physiological conditions signify the possible role of oligomerization in the
multifunctional activities of lactoferrin molecule during infections and in disease targeting signaling pathways. Here we
report the purification and physicochemical characterization of high molecular weight biomacromolecular complex
containing bovine lactoferrin ($250 kDa), from bovine colostrum, a naturally enriched source of lactoferrin. It showed
structural similarities to native monomeric iron free (Apo) lactoferrin (,78–80 kDa), retained anti-bovine lactoferrin
antibody specific binding and displayed potential receptor binding properties when tested for cellular internalization. It
further displayed higher thermal stability and better resistance to gut enzyme digestion than native bLf monomer. High
molecular weight bovine lactoferrin was functionally bioactive and inhibited significantly the cell proliferation (p,0.01) of
human breast and colon carcinoma derived cells. It induced significantly higher cancer cell death (apoptosis) and
cytotoxicity in a dose-dependent manner in cancer cells than the normal intestinal cells. Upon cellular internalization, it led
to the up-regulation of caspase-3 expression and degradation of actin. In order to identify the cutting edge future potential
of this bio-macromolecule in medicine over the monomer, its in-depth structural and functional properties need to be
investigated further.
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Introduction
Clinical and mechanistic research over the past few decades has
indicated significant relationships between nutrition and health.
The clinical studies with bovine milk derived cancer preventive
multifunctional protein lactoferrin (bLf) are currently a promising
field of research. Lactoferrin (Lf) is an iron binding ,78–80 kDa
glycoprotein of the transferrin family found to be widely
distributed in mammalian milk and most other exocrine secretions
such as tears, nasal and bronchial mucous, saliva etc. [1]. Lf
comprises of ,700 amino acids with two symmetrical lobes
forming a single polypeptide chain. Each lobe is further sub-
divided into two domains that harbor the iron binding sites [2]. In
its natural form, native monomeric-bLf (NM-bLf) is approximately
15-20% saturated with Fe3+ ions [3]. bLf’s role in mammalian iron
homeostasis, organ morphogenesis, and bridging innate and
adaptive immune functions has resulted in its potential applica-
tions in the medical field, along with its wide use as a current
nutraceutical and a safe food supplement [1,4,5]. More recently,
based on the success of animal feeding studies and human clinical
trials, bLf has gained significant attention for its prospective use as
a safer anti-cancer chemopreventive and therapeutic agent [5,6,7].
Because of the worldwide interest in bLf’s health and medical
applications, investigators for several decades have searched for
the most convenient way to produce bLf. Today, native ,78–
80 kDa bLf is mostly produced at a commercial scale from skim
milk or whey and bovine colostrum (BC) [4]. When compared to
milk, BC is a naturally rich source of bLf, known to contain 1.5–
5.0 g L21 of bLf. BC is a thick yellow fluid produced during the
first few days after calf’s birth. It is known to contain immune, and
growth factors to support the growth of the young calf, and also to
prevent gastrointestinal infections until the calf develops its own
active immune defense [8].
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Attempts have also been made to explore the multifunctional
nature of Lf. Considering Lf’s apparently higher concentrations
found in mammalian secretions during the acute phase of
infection, inflammation, and its interactions with a range of cells
and biomacromolecules (proteins, DNA, oligosaccharides, mono-
nucleotides), a possible role of oligomerization of Lf has been
suggested [9]. Earlier, it has been demonstrated that tetramer is
the dominating form of human Lf (hLf) found under physiological
conditions [10]. Being an acute phase protein with conformational
flexibility, Lf can self-assemble into larger structures. However,
molecular level explanation for this process is scarce, and
investigations are still underway to unravel this property of Lf.
Recently, by employing different techniques such as gel filtration,
soft laser ablation, small-angle X-ray scattering (SAXS), and light
scattering (LS), hLf has been reported to oligomerize into several
high molecular weight (HMW) aggregates (70 kDa–800 kDa). The
level of oligomerization was reported to depend on the concen-
trations of Lf, KCl, NaCl and also on the duration of the protein
storage in solution [11]. Interestingly, the addition of oligonucle-
otides, oligosaccharides, or mononucleotides to hLf in the presence
or absence of KCl accelerated the oligomerization rate leading to
the formation of associates containing ten or more protein
molecules. The presence of ions, ATP, NAD, nucleotides, DNA
or polysaccharides can further effect the self-association of Lf
molecule under physiological conditions [11]. These findings
suggest the importance of oligomerization for the multifunctional
activities of Lf during host–pathogen interactions, and also in
targeting cellular and molecular components of disease signaling
pathways.
Chromatographic analysis of bovine milk reveals that the bLf is
also found to elute as high molecular weight (HMW) mass
complexes corresponding to its monomers, dimers and trimers
[12]. Moreover, thermal treatments have been reported to induce
bLf aggregation into high molecular weight polymers, and this self-
association depends on iron saturation. The thermal stability of
bLf markedly increases with iron saturation leading to decrease in
the formation of larger aggregates [13]. The oligomerization of
bLf therefore can have, varied implications for its biological
functions and iron binding abilities. Whether HMW-bLf aggre-
gates/oligomers retain their functional activities like monomer is
presently unknown. Due to extensive health promoting activities of
monomeric bLf, it becomes essential to unravel the biological
functions of HMW-bLf/oligomers of bLf. In this study, we first
investigated if it was possible to purify HMW-bLf/oligomers of bLf
from BC which is known to contain a high concentration of bLf.
We then tested if the HMW-bLf/oligomeric bLf was structurally
and immunochemically similar to a native monomeric bLf (NM-
bLf). As a proof of concept, by using robust in vitro cell bioassays
with human breast (MDA-MB-231) and colon cancer (SW480) cell
lines from ATCC, we further determined if HMW-bLf/oligomeric
bLf potentially targeted cancer cell proliferation and cell death.
Another ATCC cell line FHs 74 Int, derived from normal human
fetal intestine has been reported to show mature epithelial-like
characteristics [14]. It was also employed to investigate the effects
of HMW-bLf on normal cells.
Materials and Methods
i) Purification of HMW-bLf from bovine colostrum whey
The colostrum sample was obtained from an Australian farm,
which was milked normally during postpartum/postnatal period
(first 2–4 days after calf’s birth). The sample was obtained with the
permission from the farm to collect and use it for the study. To
obtain the whey proteins, the high viscous colostrum sample was
diluted with sterile PBS (pH 7.4). Diluted colostrum sample was
skimmed by centrifugation at 30006g at 4uC for 30 min. The fat
(yellow layer) was discarded, and the supernatant was collected
and processed immediately or kept frozen at 220uC.
Casein removal by acid precipitation. The skimmed
diluted bovine colostrum sample as obtained above was acidified
by 1 M HCl until it reached pH 4.6 to achieve isoelectric
precipitation of casein. The precipitated casein was removed by
centrifugation (35006g for 30 min at 4uC); the supernatant was
collected, and the pH was adjusted to pH 7.4.
Cation-exchange chromatography. HMW-bLf was further
purified using cation exchange chromatography on SP-Sepharose
following the modified procedure of Van Berkel et al. [15]. Briefly,
the column was packed with SP-Sepharose food grade big beads
(Amersham biosciences, 17-0657-03). Before first use, the station-
ary phase was washed with 5 column volumes of water followed by
5 column volumes of 1 M NaCl. It was left in 1 M NaCl for 12 h
and then in 5 column volumes of water. The skimmed colostrum
after casein removal was diluted in the ratio of 1:1 with the dilution
buffer (0.04 M NaH2PO4, 0.8 M NaCl, 0.04% (v/v) Tween 20,
pH 7.4), and filtered through 0.45 mm and 0.22 mm filters. The
diluted colostrum sample was then loaded in the column and
allowed to pass through the column at a flow rate of 0.3 mL
min21. Following this, the SP-Sepharose was repeatedly washed
with washing buffer (0.02 M NaH2PO4, 0.4 M NaCl, 0.02% (v/v)
Tween 20, pH 7.4) to remove the unbound whey proteins. Bovine
Lf was then eluted with the elution buffer (0.02 M NaH2PO4, 1 M
NaCl, pH 7.4). The column was run at a flow rate of 3 mL min21.
The eluted fractions were dialyzed extensively with a 100 kDa cut
off dialysis membrane (Spectrum Labs) against sterile Milli-Q
water for 24 h. The purity check and the characterization of
eluted fractions were further carried out as described in the
following section.
ii) Characterization of HMW-bLf
SDS-PAGE and Western blotting. The purity and molec-
ular weight of purified fractions were analyzed by SDS-PAGE.
Following electrophoresis, Western blotting was carried out to
confirm the purity and identity of HMW-bLf. The protein was
transferred on to a PVDF membrane and probed for bLf with goat
anti- bLf antibody (Bethyl Laboratories) diluted in the ratio of
1:1000 for 1 h at 37uC and secondary anti-goat HRP (Sigma-
Aldrich) for 1 h at 37uC with appropriate washing with TBS-T
(137 mM NaCl, 20 mM Tris, 0.1% Tween 20, pH 7.6). The
membrane was developed using ECL chemiluminescence reagent
(GE) in ChemiDoc XRS gel doc (Bio-Rad). Protein samples were
freeze-dried for further characterization studies.
Dissociation of HMW-bLf into monomers and
dimers. In order to identify the homogeneity of HMW-bLf,
analysis of the components of HMW-bLf was further carried out
by dissociating the complex into its dimeric and monomeric forms
in the presence of 1 M NaCl as described earlier for hLf [11]. The
study reported that hLf oligomers dissociate fast and almost
completely to monomers in the presence of high concentrations
($1.0 M) of Na+ or K+. Briefly, 3 mg mL21 of HMW-bLf was
dissolved in 50 mM Tris HCl (pH 7.5) containing 1 M NaCl and
incubated for 1 day at 37uC. SDS-PAGE was carried out to
analyze the dissociation of HMW-bLf complex into its compo-
nents [11]. Western blotting was carried out to analyze the
obtained protein bands by goat anti- bLf (Bethyl Laboratories)
diluted in the ratio of 1:1000 to confirm the presence of lactoferrin.
Detection of Lipopolysaccharide (LPS) content. The
presence of any LPS activity was measured using E-Toxate assay
kit (Sigma-Aldrich). Briefly, 10 mg of purified and freeze-dried
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HMW-bLf protein was dissolved in endotoxin-free water to
prepare a test stock solution of 10 mg mL21, from which serial
dilutions of the protein were made to obtain 1, 0.5, 0.1 and
0.01 mg mL21 solutions. Endotoxin standards were prepared
from the stock solution (400 EU mL21) to obtain standards of
different endotoxin concentrations of 40, 4, 0.4 and 0.04 EU
mL21 solutions. Endotoxin free water supplied with the kit was
used as a negative control. E-Toxate reagent working solution
containing Limulus Amebocyte Lysate (LAL) was prepared
according to the manufacturer’s instructions. To 0.1 mL of the
test/standards/controls, 0.1 mL of E-Toxate reagent working
solution was added in 10675 mm sterile fresh glass tube. The
tubes were covered with parafilm and were incubated at 37uC for
1 h without disturbance. After 1 h the tubes were taken out and
observed for gelation by tilting them to 120u. The formation of a
solid gel was considered a positive result. Semi-solid and watery
gels were considered as negative for endotoxin activity. The final
endotoxin concentration in the test samples was calculated as;
Endotoxin (EU mL-1) = (1/Highest dilution at which the sample
was positive)*(Lowest dilution at which endotoxin standard found
negative), and it is represented as endotoxin units per mg of the
protein.
Determination of iron content in HMW-bLf. The iron
saturation level in purified HMW-bLf was determined as
described earlier by Kanwar et al. (2008) [16]. Briefly, to 1 mL
of each sample, 50 mL of ascorbic acid was added and allowed to
stand for 10 min. Iron standards representing a range of iron
concentrations and blank (Milli-Q water) were used to plot a
calibration curve. Samples were then centrifuged at 10000 rpm for
20 min. 500 mL supernatant collected from each sample was
added into new tubes containing 100 mL of alkaline acetate
solution followed by addition of 75 mL of tripyridyl solution. Two
hundred microliters of each solution were then transferred into an
optically clear 96 well plate, and the absorbance was read at
550 nm. Commercially obtained native LPS free monomeric bLf
(NM-bLf) was used to prepare iron saturated (Fe-bLf) and iron free
(Apo-bLf) according to the previously described method developed
in our laboratory by Kanwar et al. (2008) [5,16]. These forms were
used as controls for all the assays.
Differential scanning calorimetry (DSC). 5 mg of bLf was
measured accurately by sensitive balance and sealed into an
aluminum pan. DSC (TA instrument DSC Q200) scans were
programmed in the temperature range of 35–110uC and at
heating rate of 10uC min21. Native monomeric bovine lactoferrin
(NM-bLf) ,78 kDa was used as a control, along with its iron
depleted (Apo-bLf) and iron saturated (Fe-bLf) forms to determine
the thermal stability of these proteins.
Fourier Transform Infrared Spectroscopy (FTIR)
analysis. Samples were mixed with 200 mg of KBr (Sigma-
Aldrich) powder and pelleted into a KBr disc using a hydraulic
press. FTIR spectroscopy (Bio-Rad with OPUS 5.5 software)
analysis was performed between 4000 and 450 cm21 at a
resolution of 4 cm21 averaging 10 scans.
Gut enzyme intestinal digestion assay. Omnizyme cock-
tail represents most of the gut enzymes responsible for digestion of
proteins, carbohydrates and fats [14]. Omnizyme (Rainrock
Nutritionals) enzyme solution was added to the purified HMW-
bLf (1:50) to investigate its stability against gut enzymes. The
supernatants collected at different time intervals of (4 h, 6 h and
8 h) were heated at 42uC for 7 min to arrest the enzyme activity
and all samples were analyzed by SDS-PAGE.
iii) Cell bioassays
MDA-MB-231, SW480 and FHs 74 Int cells were obtained
from American Type Culture Collection (ATCC, supplied by
Cryosite). MDA-MB-231 has been derived from Homo sapiens
(female) breast carcinoma while SW480 cell line was derived from
Homo sapiens (male) colorectal adenocarcinoma. Both MDA-MB-
231 and SW480 cell lines were epithelial and had adherent growth
properties. Both the cell lines were routinely cultured in L-15
media containing 10% FBS at 37uC without CO2. FHs 74 Int is a
cell line from normal human fetal intestinal tissue, and it was
grown in DMEM with 10% FBS at 37uC under 5% CO2.
Cell cytotoxicity (LDH release) assay. Cytotoxicity caused
by treatments with HMW-bLf and other control forms of bLf was
measured by release of lactate dehydrogenase (LDH) following
cellular injury or cytotoxic insult. The cytotoxicity detection kit
(Roche Applied Science) was used according to manufacturer’s
instructions. The assay is based on calculating the LDH leakage
into the culture medium after 24 h following exposure of cells to
different treatments. LDH is constitutively present in all cells and is
released into supernatant due to cell membrane damage. MDA-
MB-231 SW480 and FHs 74 Int cells were treated with media
containing different treatment concentrations (800, 1600, 2400,
3200 mg mL21) of HMW-bLf for 24 h. Each treatment was
carried out three times, in triplicates. The absorbance values were
measured by using a SH-1000 lab absorbance microplate reader
(Corona Electric) at 492 nm with reference wavelength at 620 nm.
All values were the product of background subtraction with media
alone reacting to the LDH reagent. Addition of Apo-bLf, Fe-bLf
and HMW-bLf to the media did not alter the background reading.
The % cytotoxicity was calculated by the formula; Cytotoxicity
% = [(Exp. value-Low control)/(High control-Low control)]6100.
Negative control (Low control) used was the cell culture
supernatant of untreated cells and positive control (High control)
representing the maximum value of LDH release was the cell
culture supernatant of the cells treated with 1% (v/v) Triton X-
100 (Sigma-Aldrich, Sydney, Australia). All obtained values for
treatments are represented relative to untreated control value set
to zero.
Cell proliferation assay. The inhibition of cell proliferation
caused by bLf treatments was analyzed by determining the DNA
content of the cell using CyQuant assay kit (Invitrogen) as per
manufacturer’s instructions. Briefly, viable MDA-MB-231 and
SW480 cells were plated, initially at a concentration of
26105 cells/mL in 96 well microplates and incubated overnight.
Cells were then treated with fresh media containing different
treatment concentrations (800, 1600, 2400, 3200 mg mL21) of
HMW-bLf for 24 h and the media was aspirated out. The
CyQuant reagent was then added to the cell pellet, and the
corresponding fluorescence from the DNA was measured using a
fluorescence reader at an excitation wavelength of 490 nm and
emission of 530 nm. Treatments with different doses of HMW-bLf
were carried out in triplicates, and the assay was repeated three
times. Media with 20% FBS was used as a positive control.
Background measurements for the plate alone with CyQuant
reagent were subtracted from the test values.
Measurement of cell death by Flow cytometry. MDA-
MB-231, SW480 and FHs 74 Int cells were treated with different
concentrations of HMW-bLf for 24 h, and then trypsinized. Cell
pellets were washed with sterile PBS and resuspended in 500 mL
sterile PBS containing 0.1 mg mL21 Propidium Iodide (PI)
solution. PI is a fluorochrome that intercalates into double-
stranded nucleic acids. After 15 min of incubation in dark at room
temperature, the cells were analyzed for cell death (viability
counts) using Flow cytometry (BD FACSCanto II). Untreated
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unstained cells were used to set up the instrument for acquisition,
and the gating was adjusted to have ,1% PI positive cells. The
test samples were acquired after this under the same settings, and
the percentage of cells in the PI positive gate was considered as the
percentage dead cells.
Cellular internalization of HMW-bLf. Cellular uptake of
HMW-bLf was studied by immunofluorescence and visualized by
confocal microscopy. SW480, MDA-MB-231 and FHs 74 Int cells
were seeded in an 8-chamber multi-well slide (BD falcon) at a
density of 16105 cells/well and were then treated with 800
mg mL21 of HMW-bLf for different time intervals in assay media
(basal cell media with 1% FBS). Cells (to be treated as well as the
untreated) were pre-conditioned to the assay media for 24 h before
the actual assay by culturing in the assay media and remained
healthy. Following treatment, the medium was removed, and the
cells were washed thoroughly using PBS (pH 7.4) to remove
unbound and non-internalized HMW-bLf from the cell layer,
followed by fixation with 4% paraformaldehyde. After fixation, the
cells were permeabilized with 0.1% TritonX-100 for 5 min on ice.
Blocking was carried out with 2% sterile rabbit serum in PBS and
cells were then incubated with primary antibody, goat anti-bovine
lactoferrin (Bethyl Laboratories) at a dilution of 1:200 in PBS at
37uC for 1 h. The primary antibody was then removed and after
washing, cells were incubated with anti-goat IgG-FITC conjugate
(Sigma-Aldrich) and counterstained for actin with Phalloidin-
AlexaFluor 568 (Invitrogen) and nucleus with DAPI in fluorshield
(Sigma-Aldrich). The slides were imaged using TCS SP5 Leica
broadband confocal microscope and processed using LAS-AF
software. Media containing 1% FBS was used to avoid any
protein-protein interactions during treatments. Because we used
the lower FBS concentration in the assay media than the normal
growth media, the cell viability was checked with trypan blue
exclusion assay, before performing cellular uptake studies. No
difference was noted between the cells ability to exclude the trypan
blue dye when cells were grown in media containing 10% FBS or
of that in 1% FBS for 24 h (Figure S1 in File S1). The 800 mg mL-1
of HMW-bLf concentration was used for its comparatively lower
cytotoxic effects on cancer cells. As a result following incubation
with these treatments, lesser cell detachment (of dying/dead cells)
was observed from the slide, and the cell monolayer survived the
staining and imaging procedure.
Caspase-3 assays. Activation of cellular apoptosis was
determined by caspase-3 activation assay using the method
described by Fujie et al. [17]. Cells were treated with different
concentrations of HMW-bLf and Fe-bLf (3200 mg mL21) for 24 h.
Cells were lysed, centrifuged, and supernatant containing 100 mg
mL21 protein lysates were taken for analysis from each treatment.
50 mL of mixture reagent (Dithiothreitol (DTT) in radio-immu-
noprecipitation assay RIPA buffer solution) was added. Finally,
6 mL of substrate acetyl-Asp-Glu-Val- Asp p-nitroanilide (Sigma-
Aldrich) dissolved in dimethyl sulfoxide (DMSO) at 10 mg mL21
was added to all samples. The plate was then incubated for
180 min at room temperature in dark. Level of caspase-3
expression was quantified by using SH-1000 lab absorbance
microplate reader (Corona Electric) at 405 nm.
The activation of cleaved caspase-3 was also confirmed using
Western blot for cleaved caspase-3. Cells were treated with
different concentrations of HMW-bLf, Apo-bLf and Fe-bLf
(3200 mg mL21) for 24 h. Cells were lysed using RIPA (Radio
Immuno-Precipitation Assay) buffer, and 75 mg of total protein
was loaded for the SDS-PAGE. The proteins were then
transferred to a PVDF membrane using Trans-Blot Turbo (Bio-
Rad) semidry transfer instrument. The membrane was blocked
using 3% skim milk for one hour after which they were probed
using cleaved caspase-3(Asp175) primary antibody (Cell Signaling
Technology) in the dilution of 1:500 at 37uC for 1 h. The primary
antibody was then removed, and the membranes were washed
thrice with TBS-T to remove unbound primary antibodies. It was
then incubated with 1:40000 anti-rabbit HRP secondary antibody
(Sigma) for 1 h at 37uC. After incubation, the secondary antibody
was removed and membrane was washed three times with TBS-T.
The membrane was developed using ECL chemiluminescence
reagent (Amersham) and viewed under Chemi-doc XRS gel
documentation system (Bio-Rad).
Statistical analysis. Data was expressed as mean values
(6SD) and Student’s t-test was performed for evaluating statistical
significance. A value of (p,0.05) denotes statistical significance,
whereas (p#0.01) denotes results that are highly significant. All
treatments were tested in triplicate, and each assay was repeated 3
times.
Results and Discussion
HMW biomacromolecular complex containing bLf was purified
from skimmed defatted, casein free colostrum whey using cation
exchange chromatography with SP Sepharose food grade big
beads. Casein from skimmed bovine colostrum was completely
precipitated at lower pH and was removed. The whey obtained
was therefore casein and fat free. Lactoferrin has an Iso-electric
point of pH 8.7 which is the highest among all the milk proteins.
Hence bLf remains positively charged even at the near neutral pH
of 7.4. It binds very strongly to the cation exchange resin whereas
other whey proteins are not strongly bound, and they get washed
off during the washing step, leaving only the bLf molecules
attached to the resin. This bound bLf was then isolated using a
strong cationic 1 M salt solution [18]. The eluted protein fractions
were then subjected to extensive dialysis. The purity of the eluted
fractions was checked by SDS-PAGE that showed a single HMW
band $250 kDa (Figure 1A). The HMW protein band on SDS-
PAGE was later identified as bLf by Western blotting using anti-
bLf antibody (Figure 1B). Native bLf as a monomer has a
molecular mass of,77–80 kDa, depending upon the glycosylation
of mature protein, the $250 kDa HMW-bLf therefore indicates a
trimer or a probably partially degraded tetramer due to its possible
interaction with Sepharose resin during purification. This
phenomenon has been reported earlier that incubation of hLf
with oligosaccharides led to the formation of unstable oligomers as
studied by gel filtration chromatography using polysaccharide
resins such as Sephadex, Sepharose 4B, etc. [11]. These authors
suggested that Sepharose, containing alternating residues of b-D-
galactopyranose and 3, 6 anhydrido-a-1-galactopyranose linked
by 1-4 bonds, could dissociate hLf oligomers. As explained above,
Lf has high affinity for such resins, thereby efficiently interacts with
them. Lf bound to these gel filtration/cation exchange chromato-
graphic resins can be eluted at high salt concentrations (KCl or
NaCl), since the high ionic strength causes dissociation of
oligomers, and Lf then can be mostly eluted as a monomer.
Interestingly, previous Sephadex G-200 chromatographic puri-
fication reports reveal that when the concentration of bLf was high
in mammary secretions due to infections such as during mastitis,
bLf was initially obtained as 77 kDa monomer, and as the
infection progressed, it was separated at approximately the size of
a trimer (,240 kDa). These observations were therefore concur-
rent with the increasing bLf concentrations during infections [19].
Another study similarly reported that the bLf, in non-lactating
mammary secretions during involution, was mainly present as
HMW complexes rather than as monomers, and majority of total
bLf existed in ,250 kDa molecular mass fractions [12]. Structural
High Molecular Weight Lactoferrin Targets Cancer Cell Apoptosis
PLOS ONE | www.plosone.org 4 September 2014 | Volume 9 | Issue 9 | e106568
studies employing the method of sedimentation equilibrium in the
ultracentrifuge, on purified preparations of bLf obtained from
commercial preparations, revealed that the purified protein
exhibited heterogeneity with respect to its molecular weight in
dilute aqueous salt solutions. The top of the cell had 76 kDa bLf
material while .200 kDa material was sedimented at the cell
bottom. These findings implied that bLf associated in the native
state in a concentration dependent manner, and aggregates as high
as trimers were obtained [20]. The nature of these intermolecular
interactions in bLf oligomers remained unknown, and mostly
investigators in the late last century, did not take bLf oligomeric
forms into consideration. There are reports that bLf dimers have
also been mistaken for IgG, because of its molecular weight that is
twice of the bLf monomer [21,22].
More recently, emerging experimental evidence indicate Lf as
an extremely conformationally dynamic protein that is prone to
self-association. The macromolecule has a dumbbell shape, well
described by a bi-axial ellipsoid with half-axis of 47 A˚ and 26 A˚
[11,13,21]. While the levels of self-association were shown to
depend on the number of conditions such as Lf concentration,
presence of salts, ligands, storage in solutions, iron saturation and
temperature, a molecular level explanation remains yet to be
understood for this phenomenon. Without salt or at physiological
salt concentrations, bLf as well as hLf reportedly self-associate in
aqueous solutions as dimers, trimers, and also as tetramers with
tetramer being the dominant form [11,21]. In these studies, gel
filtration analysis also revealed small peaks of the decamer. For
tetramer formation, which is the predominant molecular form of
Lf in human serum, tears, and breast milk, calcium dependent
oligomerization of hLf has been reported, [23]. Therefore the
purification of $250 kDa bLf oligomer in our study is in
agreement with the aforementioned findings of other investigators.
Colostrum is known to contain higher concentrations of bLf and
calcium ions than milk [8,24,25] these could have also contributed
to the self -association of bLf into HMW oligomeric complex along
with the unidentified molecular trigger(s) of self-association.
HMW- bLf molecule was also found to be dissociated into the
dimeric (,160 kDa) and monomeric (,78 kDa) forms of bLf
when kept for 24 h in the presence of 1 M NaCl. This observation
is inconsistent with earlier findings on hLf [11]. As determined by
gradient SDS-PAGE (reducing gel) analysis followed by Western
blotting with anti-bLf antibody (Figure 1C), all the three bands
were identified as bLf protein. More interestingly, a progressive
increase in the intensity of monomeric ,78 kDa band with a
simultaneous decrease in the remaining HMW-bLf band was
observed. This is clearly evident in Western blot (Figure 1C). We
Figure 1. Purification and analysis of components. A) SDS-PAGE analysis of purified HMW-bLf indicating the presence of pure $250 kDa
protein in elutes (lanes 1 and 2). B) The purified protein was confirmed to be bLf through Western blotting using anti-bLf specific antibody. C)
Dissociation of HMW-bLf in 1 M NaCl into the dimeric (,160 kDa) and monomeric (,78 kDa) forms (lane S1). These were confirmed to be bLf bands
by Western blot for the same dissociated sample (S1). The absence of any other lower bands and the detection of all the constituent bands by anti-
bLf specific antibody indicate that HMW-bLf is an oligomer formed by the interactions of monomeric bLf molecules.
doi:10.1371/journal.pone.0106568.g001
High Molecular Weight Lactoferrin Targets Cancer Cell Apoptosis
PLOS ONE | www.plosone.org 5 September 2014 | Volume 9 | Issue 9 | e106568
have also noted that since the purified HMW-bLf sample
(Figure 1B) was stored for about a year after purification and
lyophilization, a much larger bLf aggregate (polymer) in the
stacking gel was identified that showed lower mobility protein
material with a comparative decrease in its band density, than the
$250 kDa oligomeric complex band observed just after the
purification (Figure 1A). These observations are also consistent
with the earlier oligomerization studies on hLf which report that in
the presence of 1 M NaCl, the hLf oligomers dissociate slowly into
monomers whereas, during storage of dialyzed and lyophilized
protein solutions at neutral pH, the monomeric or oligomeric
forms slowly aggregate[11,26]. We also performed Western
blotting for bovine IgG to identify dimeric 2160 kDa band, and
the larger HMW-bLf aggregate band but no immunoreactivity
was observed indicating there was no contamination from IgG.
Further, no other bands that could correspond to molecular
weights of any other milk protein (lysozyme 2 14.6 kDa, a-
lactalbumin -14.12 kDa, b-lactoglobulin – 22.40 kDa, as1-casein –
33.30 kDa, b-casein – 37.50 kDa) in the dissociated sample of
HMW-bLf were observed on SDS-PAGE reducing gel (Figure 1
C), indicating their absence in the sample.
The absence of any LPS contamination and endotoxin activity
in the purified protein was confirmed using E-Toxate assay kit
which indicated the presence less than 0.04 EU/mg (Endotoxin
Units/mg) of endotoxin activity in the purified HMW-bLf
samples. This was much lower than the FDA accepted standards
[27]. Our observations thus indicate that purified HMW-bLf could
be made up of bLf molecules forming a multimeric complex due to
non- covalent, ionic interactions. These interactions were broken
in the presence of strong ionic solution (1 M NaCl) and results in
the appearance of more intense low molecular weight monomeric
as well as dimeric forms. In the existing literature, despite the
emerging data on Lf oligomerization/self-association, little is
known about the nature of the chemical linkages/binding
Figure 2. Physico-chemical characterization of HMW-bLf. A) Fourier transform infra-red (FTIR) spectra of HMW-bLf indicating characteristic
peaks and compared with other forms of bLf. B) Differential scanning calorimetry thermograms of the different bLf forms C) SDS-PAGE showing the
comparative resistance of HMW-bLf to Omnizyme (human digestive enzyme cocktail) treatment. It also gives an indication that HMW-bLf is an
oligomer made of bLf monomers; because upon digestion HMW-bLf besides dimers and trimers does not release any other fragments lower than
,78 kDa apart from the ones produced from the digestion of commercially pure NM-bLf.
doi:10.1371/journal.pone.0106568.g002
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interactions that result in the formation of Lf-Lf complexes. Ionic,
thiol/disulfide and hydrophobic interactions may all be involved
in these intermolecular interactions. Earlier findings on thermal
aggregation of bLf molecules proposed that the bLf aggregation
proceeded via a combination of non-covalent interactions and
intermolecular thiol/disulphide reactions that did not require free
thiol residues. Specifically, the thermal aggregation of iron
saturated bLf was mainly driven by non-covalent interactions,
with intermolecular thiol/disulphide reactions also observed above
80uC [13]. Using force field based molecular modeling of the
protein–protein interaction free energy, it was demonstrated that
at neutral pH, Lf forms highly stereo-specific dimers. This self-
association is driven by a high charge complementarity across the
proteins’ contact surface [21].
Because of its iron binding properties, Lf is known to exist in two
forms: holo-Lf (binds two Fe3+ ions, iron saturated), Apo-Lf (iron
depleted) [2]. Native Lf is only partially saturated. Therefore, we
measured the iron content of HMW-bLf and found that it
contained only 0.47% iron and thus, was more like Apo-bLf
(1.1%), when compared with other forms of bLf such as NM-bLf
(22% iron), and iron saturated bLf (Fe-bLf) .94% iron (Figure S2
in File S1). Figure 2A shows a comparison between the FTIR
spectra of HMW-bLf, NM-bLf, Apo-bLf and Fe-bLf. The
characteristic amide carbonyl stretching appeared between 1630
and 1650 cm21, the C-N stretch was observed between 1500 and
1550 cm21 while the O-C-N bend was discernible between 675
and 721 cm21 in the four forms. The Fe-O vibration band
appeared at 560 cm21 in the FTIR spectrum of Fe-bLf while it
was not pronounced in the other three spectra suggesting high iron
content in Fe-bLf (Figure S3 in File S1). This also confirms our
iron content estimation results. bLf is classified as a glycoprotein,
the bands from 900–1200 cm21 due to C–O, C–C, C–O–H, C–
O–C vibrations of the carbohydrate moiety were therefore
observed in all the four forms of bLf [28].
Exploring the thermal stability of bLf has been also important
because of its bioactivity. In order to develop a practical method
for pasteurization of bLf, the heat stability has been studied
previously. Several factors can affect the heat stability of bLf such
as pH, salts, and other whey proteins [29]. We tested the thermal
stability of HMW-bLf, Fe-bLf, Apo-bLf and NM-bLf in lyophi-
lized powder form by DSC. The thermogram of $250 kDa
HMW -bLf (Figure 2B) showed denaturation peak at 88uC, which
was the highest when compared with those of Fe-bLf, Apo-bLf and
NM-bLf, and their denaturation peaks were observed at 82uC,
74uC and 78uC, respectively. These findings suggest that the
higher thermal stability of HMW-bLf may be due to its structural
integrity as an oligomer. Among other bLf forms, the Fe-bLf was
comparatively more resistant to heat when compared to the Apo-
bLf and the NM-bLf. Similar findings have also been reported,
suggesting that an increase in protein stability depends upon the
degree of iron saturation [13,30,31]. Increased thermal stability of
Fe-bLf (holo-bLf) has been attributed to the more compact
conformation, adopted by the molecule by binding a ferric ion in
the inter-domain cleft of each lobe [2]. Slightly higher thermal
stability of the NM-bLf than the Apo-bLf could thus be attributed
to partial iron saturation status of the native protein.
From our results, and the aforementioned discussion, it can be
inferred that the interactions between the bLf molecules may
largely be ionic to form the HMW-bLf oligomer. Oligomeriza-
tion/protein aggregation is a concentration dependent process. At
high concentration of Lf and of calcium in the bovine colostrum,
the equilibrium shifts towards the formation of oligomers,
however, under dilution or at high Na+/K+ concentration the
ionic bonds are broken and they tend to shift towards existence as
monomers. We propose that HMW-bLf, which is similar to Apo-
bLf and lacks mostly the iron content, and likely contain lot of free
aspartate and tyrosine residues. This confers a very open, flexible
configuration to HMW-bLf molecule similar to Apo-bLf [32]. Due
to this, the ability of the molecule to undergo intermolecular
interactions was highly increased when maintained at a high
concentration and in the absence of any salt content, especially
iron [13]. These complex interactions in HMW-bLf appeared to
be very strong [11] and led to the formation of even larger
aggregates upon prolonged storage (Figure 1C). We have also
noticed that NM-bLf (22% iron saturated), when stored at high
concentration, displays trimers and dimers formation visualized on
denaturing SDS-PAGE condition (data not shown). In a study that
investigated the effect of iron saturation on thermal aggregation of
bLf in Apo state, it was shown that Apo-bLf associated into large
polymers by non-covalent interactions without the participation of
disulphide cross-links. The more unfolded structure of heat
sensitive Apo-bLf may have increased the exposure of non-
covalent sites normally buried in the core of both lobes of the
protein, thereby favoring intermolecular interactions and the
formation of larger aggregates [13]. The in-depth molecular and
biophysical characterization of the HMW-bLf needs to be
investigated further with more powerful proteomics tools such as
Mass spectroscopy and Circular Dichroism, in order to identify the
chemical as well structural changes/linkages in the oligomer. To
determine spontaneous association of bLf in physiologically
simulated solution SAXS and LS can be employed to analyze
the oligomeric states of HMW-bLf.
The consumption of test drinks containing Apo-bLf and iron
saturated bLf in human volunteers has shown that Apo-bLf is
more susceptible to in vivo gut digestion, than the corresponding
iron-saturated form [33]. Similarly, we have reported earlier the
resistant nature of Fe-bLf towards Omnizyme (a digestive enzyme
cocktail) [5]. In the current study, HMW-bLf was found to be
more resistant to Omnizyme digestion in vitro, even after 4, 6, and
8 h incubation periods. Figure 2C shows that HMW-bLf in lanes
2, 3 and 4 showed excellent stability to digestion, with digested
forms appearing as 150–160 kDa dimers at various intervals of
time (4, 6 and 8 h) while faint bands at ,78, 50 and 25 kDa. In
the case of NM-bLf, in lanes 5, 6 and 7 the 78 kDa bands have
completely disappeared and digested to its peptides that appeared
at 51, 37and ,25 kDa. HMW-bLf’s comparatively much stronger
resistance to gut enzyme digestion despite having far lower iron
content than NM-bLf (0.47% versus 22%).This can be explained
in terms of the robustness of its structure being a larger
biomacromolecule/oligomer. This property will therefore prove
beneficial for its potential use as a nutraceutical. In that case, if
given orally there will be an increase in the in vivo bioavailability
of HMW-bLf to the required sites of the action in the body, e.g.,
tumor/infected and inflammatory tissues as compared to NM-bLf,
which is comparatively more prone to digestion. This assay also
gives an insight into the components of HMW-bLf and indicates
that HMW-bLf appears not to be made up of any other
component than that of NM-bLf. The fragments that are
generated by the Omnizyme digestion show that NM-bLf (Lanes
4, 5 and 6) can be degraded into a large C- terminal lobe with a
part of the N-terminal region and the connector seen as a 51 kDa
band. The C-terminal lobe on further digestion produced the
band at 36 kDa. This is not a homologous digestion, and it does
not produce two equal sized fragments hence resulting in a few
smaller fragments seen at 25 kDa [34]. The observation that
below ,78 kDa, the HMW-bLf also produces the same set of
bands as that of NM-bLf (Figure 2C, Lanes 1–3 and 4–6
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respectively) thus is in agreement with our dissociation findings of
HMW-bLf (Figure 1C) that it was comprised of bLf monomers.
We have shown earlier that 100% iron-saturated bLf form (Fe-
bLf) when given orally to mice prior to chemotherapy caused its
augmentation [16]. Significant eradication of large tumors in
combination with anticancer drugs was observed. However, 20%
iron-saturated (NM-bLf) or Apo-bLf remained ineffective in
eradicating these tumors, owing to their high degradation in the
gut as compared to Fe-bLf. In order to increase the more
bioavailability of Fe-bLf to the tumour sites, more recently, we
have developed a novel nanodrug delivery system (alginate-
enclosed chitosan–calcium phosphate-loaded Fe-bLf nanocarriers)
for oral delivery. By employing human colon xenograft model, we
reported that nanoformulated Fe-bLf when fed orally led to the
complete inhibition of tumorigenesis in prevention mode. A
complete tumor rejection through regression, in the treatment
mode was also observed [5]. These nanocarriers thus led to the
increased bioavailability of Fe-bLf to the tumor sites, and were
found to be safe and nontoxic. Similarly, another study has shown
that the anti-tumor effects of NM-bLf on melanoma cells can be
enhanced with liposomalization. A lipid delivery system (lipo-
somes) was used to prevent the NM-bLf from proteolysis or
neutralization by serum proteins [35]. Considering the findings
that tetramer is reported to be the dominating form of hLf
observed under physiological conditions [10,23], and bLf self-
associates as dimers, trimers and tetramers in mammary secretions
during infection and involution [12,19], it may imply that the
physiological existence of Lf oligomers, can therefore be a
protection strategy acquired by multifunctional Lf against
proteolysis or neutralization by serum proteins.
Earlier it has been shown that NM-bLf decreased the viability of
breast cancer cell lines HS578T and T47D by inducing a 2-fold
increase in apoptosis, and decreased the proliferation rates as well
in both the cell lines [36]. A similar effect of bLf was seen on colon
carcinoma [37] and in vivo on tumors of melanoma, EL-4 T-cell
thymic lymphoma and Lewis lung cancer cells [16]. To test the
anticancer activities of HMW-bLf, we employed MDA-MB-231
(human breast carcinoma) and SW480 (human colorectal adeno-
carcinoma) cell lines. Figure 3 (A and B) shows the cytotoxic effects
of HMW-bLf. It was assessed by measuring the leaked LDH
enzyme (as a cell viability biomarker), from dying or dead cells
(early/late apoptotic and necrotic) due to their damaged cell
membranes. HMW-bLf was found to be effective in a concentra-
tion dependent manner in inducing cell cytotoxicity in both MDA-
MB- 231 and SW480 cells. The cytotoxicity values of HMW-bLf
and Fe-bLf at the highest concentration used (3200 mg mL21),
were highly significant (p,0.01) with 90% and 76% cytotoxicity
observed respectively. Similarly, when compared with the other
control forms of bLf, 3200 mg mL21 of HMW-bLf also showed
significantly highest cytotoxicity in SW-480 cells. Though, among
all the concentrations of HWW-bLf tested on SW480 cells, it
showed lowest cytotoxicity values at a concentration of 800 mg
mL-1 but the effect was still statistically significant (p,0.05) when
compared to the untreated cells’ (value set at zero). The
cytotoxicity of HMW-bLf towards non-cancerous human cells
(of normal intestinal origin) was also tested by treating FHs 74 Int
cells with its different concentrations. A significant increase in the
LDH release activity corresponding to 15% cytotoxicity was
observed only at the highest concentration (3200 mg mL21) of
HMW-bLf, as shown in Figure 3 C. More importantly, in HMW-
bLf treated colon cancer cells (SW480), the corresponding
cytotoxicity values at all the concentrations tested were signifi-
cantly higher (P,0.01) than those obtained with FHs 74 Int cells.
Moreover, at HMW-bLf treatments(800 mg mL21, 1600 mg mL21
and 2400 mg mL21), LDH release activity from FHs74 Int cells
was significantly lower than that of untreated cells. The presence
of Lf in mammalian milks and bovine colostrum has an important
role for the normal gut cell growth, maturation and repair in
young ones. It could thus possibly be a therapeutic action of the
HMW-bLf in repairing membrane damage, occurred normally to
these normal intestinal cells under in vitro culture. A maximum of
LDH release corresponding to 33% cytotoxicity (p,0.01) was seen
with NM-bLf 3200 mg mL21 treatment to FHs74Int cells. There
was no significant difference observed among the cytotoxic
activities of Apo-bLf (2066.5%), NM-bLf (33615%) and
HMW-bLf (1564.2%) at 3200 mg mL21. However, when
compared at 1600 mg mL21, NM-bLf caused significantly higher
cytotoxic effect on FHs74 Int cells than HMW-bLf at the same
concentration. It is important to note here that among all the
treatments, NM-bLf induced highest 33% cytotoxicity to the
normal intestinal cells. The non-toxicity of bLf to normal cells/
tissues during long-term feeding has been clearly shown through
number of in vivo animal studies, and oral feeding trials in human
volunteers and colon cancer patients [4,5,6,16]. It has been
approved by the Food and Drug Administration (FDA) of United
States in 2001, and later by European Food Safety Authority as a
dietary supplement in food products [38,39]. Moreover, FHs 74
Int is a fetal derived intestinal cell line, known to grow as normal
enterocytes. Considering Lf’s intense affinity for iron [1,32], it can
be explained that FHs 74 Int cells’ requirement of iron, for their
cell viability, appears to be targeted by both Apo-bLf (iron free)
and NM-bLf (partially saturated with iron) thus showing
significantly higher cytotoxicity values than Fe-bLf. On the other
hand, HMW-bLf although showed very low iron content but
having a more robust complex molecular structure, might not bind
iron as fiercely as Apo-bLf and NM-bLf do. Therefore, it showed
comparatively less cytotoxicity than Apo-bLf and NM-bLf. These
observations need follow-up investigations to determine the
complete safety profile of HMW-bLf towards the normal cells.
Since recent reports suggest that LDH release measurements
can underestimate the cytotoxicity caused by compounds causing
cell cycle arrest [40], the cytotoxic effects of HMW-bLF were also
studied by Flow cytometry using PI staining. Figures 3 (D and E)
and Figure S4 in File S1, show the cell death induced by HMW-
bLf in cancer cells and FHs74 Int cells, respectively. PI test values
appeared higher (Figure 3 D and E) than the LDH release assay
(Figure 3 A and B). However, the results of the two assays were in
general agreement and showed that HMW-bLf targeted cell death
in a dose-dependent and cell specific manner. Even within cancer
cells from different tissues, it was significantly more cytotoxic
towards MDA-MB-231 cells than SW480 cells.
To determine the growth inhibitory properties of HMW-bLf,
we further assessed the proliferation of MDA-MB-231 and SW480
cells after treatments for 24 h using the CyQuant assay. Figure 4
(A and B) shows that HMW-bLf decreases the rate of cell
proliferation in a dose-dependent manner. At the highest dose, it
significantly (p,0.01) inhibited the proliferation of both MDA-
MB- 231 and SW480 cells (up to 90%), a better rate than any
other control forms of bLf. Furthermore, observation into the
effects of HMW-bLf on cell morphology revealed that cells after
treatments for 24 h, exhibited poor growth showed altered
morphology with high levels of cellular fragmentation and
apoptotic bodies. Both cell lines used in this study showed
detachment from culture dish bottom and floating dead cells were
mostly observed, when highest concentration of HMW-bLf was
employed (Figure 4 C and D).
NM- bLf is known to be internalized into live cells through cell
surface (membrane) receptor mediated endocytosis mechanism
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[1,41]. The published data report that transferrin receptor (TfR),
lactoferrin receptors and low density lipoprotein receptor-related
protein receptors (LRPs) play a crucial role in facilitating the
internalization of bLf inside cells[42,43]. Using both colon and
breast cancer cells it was observedthat bLf internalized into the
membrane, cytoplasm and nucleus in a time dependent fashion
(unpublished studies from our laboratory). Therefore immunoflu-
orescence was carried out in order to determine whether the
oligomerization state of HMW-bLf affects its cellular internaliza-
tion and receptor binding properties using MDA-MB-231 SW480
and FHs74 Int cells (Figure 5 and Figure S5 in File S1). Since the
cytotoxicity of HMW-bLf was observed in a concentration
dependent manner, only lowest concentration (800 mg mL21)
was used. Therefore following incubation, lesser cellular detach-
ment (of dying/dead cells) was observed from the slide making the
immunostaining and imaging possible. The confocal microscopy
images indicate that beginning at 30 min after incubation, there
was a rapid internalization of HMW-bLf by the three cell types.
The presence of green fluorescence signal of bLf specific antibody
immunostaining was mainly seen on the cell surface and cell
membrane. Since internalization is a time dependent process, it
was more evident at earlier time points of incubation (30 min and
4 h). HMW-bLf was also found to be localized along the
perinuclear region in 4 h. In the images obtained after 6 h and
8 h of incubation periods, HMW-bLf was seen to be internalized
into the nuclei of cancer cells. This indicates that bLf in its
oligomeric state retains its ability to interact with receptors and is
taken up by the cells in time dependent fashion, although further
investigations are needed to determine the receptor-ligand
interactions completely. Taken together, the results of cellular
internalization, LDH release and CyQuant assays reveal that
cellular uptake of HMW-bLf even at 800 mg mL-1 proved
effective; where internalized HMW-bLf displayed its functional
bioactivity in terms of inducing significant cytotoxicity (LDH
release) and anti-cell proliferative activity in cancer cells.
Interestingly, the degradation of actin network within the cells
Figure 3. Cytotoxic effects of HMW-bLf. A B and C represent the cellular cytotoxicity measured by LDH release assay induced by HMW-bLf in a
concentration dependent manner, in MDA-MB-231 (human breast carcinoma) SW480 (human colorectal adenocarcinoma) and FHs 74 Int (normal
intestinal cells) cells. D and E show the cell death (mortality count) as measured by Flow cytometry using propidium iodide staining (* p,0.05 and **
p,0.01). Other forms of bLf were used for comparison.
doi:10.1371/journal.pone.0106568.g003
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was observed by the reduced fluorescence intensity of phalloidin -
AlexaFluor 568 stain (red fluorescence). This shows that the
cellular uptake of HMW-bLf triggers the process of apoptosis
resulting in the loss of actin framework which acts as a substrate
for caspase-3 and its downstream products [44]. Figure 5B shows
the high magnification image of HMW-bLf internalization in
SW480 cells after 4 h with the arrows pointing out at the cells that
have internalized HMW-bLf and thereby showing the degradation
of actin. An arrow head points to the cell with intact actin
structure that has not taken up HMW-bLf. Figure 5C is a high
magnification image of HMW-bLf internalization at 6 h showing
the beginning of nuclear material degradation which is the final
stage in the apoptotic pathway.
This was further confirmed by studying the release of caspase-3,
considered as the final executioner enzyme in the apoptotic
pathway [45]. Treatment with HMW-bLf induced a statistically
significant increase in the levels of caspase-3 secretion in both
MDA-MB-231 and SW480 cells, thereby confirming the induction
of cell death by apoptosis, (Figure 6 A and B). In both SW480 and
MDA-MB-231 cells, HMW-bLf treatment significantly (p,0.01)
up-regulated caspase-3 levels, and in SW480 cells the effect was
also significant when compared with control Fe-bLf at 3200
mg mL-1. The rapid internalization of HMW-bLf into the
cytoplasm and nuclei of cancer cells seems to lead to the initiation
of gene transcription within the cell to trigger apoptotic signals
thereby, resulting in cell death via apoptosis. We and other
researchers have also shown that internalization of NM-bLf into
the cell and nucleus can regulate gene transcription of its
receptors, cytokines such as transforming growth factor-b and
survivin [1,46,47]. bLf has been shown to activate both extrinsic
and intrinsic apoptotic pathways through activation of different
caspases [1,7]. To confirm the results obtained using the caspase-3
activity assay, Western blot was performed for cleaved caspase-3,
which is the active form of the apoptosis activator enzyme. Both
SW480 and MDA-MB-231 cells show upregulation of the cleaved
caspase-3 expression upon treatment with HMW-bLf. Especially,
high expression of cleaved caspase-3 is seen in the 3200 mg mL21
treatments of both Fe-bLf and HMW-bLf in MDA-MB-231 and
Figure 4. Cell growth inhibition. HMW-bLf decreases the cellular proliferation of MDA-MB-231 and SW480 (A and B respectively) cells in a
concentration dependent manner. The cell fate was also monitored by analyzing the cell morphology (C – MDA-MB-231 and D – SW480) which clearly
indicates cell death. (* p,0.05 and ** p,0.01)
doi:10.1371/journal.pone.0106568.g004
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with 1600 mg mL21 in SW480 (Figure 6C and D). This indicates
the ability HMW-bLf to induce apoptosis by activating caspase-3.
Conclusions
In summary, our current in vitro study using breast and colon
cancer cells showed for the first time the anticancer efficacy of
$250 kDa HMW-biomacromolecular complex containing bLf.
HMW-bLf was purified to homogeneity from Australian bovine
colostrum. We have identified its unprecedented and interesting
properties. HMW-bLf besides having molecular and structural
similarities to Apo-bLf in terms of iron content also retains its
antibody, and receptor binding properties. It possesses unique
features such as higher thermal stability and better resistance
against gut enzyme digestion than other forms of bLf monomer.
Furthermore, HMW-bLf displayed stronger anti-cancer properties
in terms of cytotoxicity and anti-cell proliferation activity. The
possible actin degradation due to increased caspase-3 activity
thereby, leading to apoptosis further signifies the need to explore
the exact level of interesting interactions exhibited by HMW-bLf
in modulating cancer cell death. The purified sample tested for its
anticancer activities was obtained through final step of dialysis
with 100 kDa MW cut off membrane, and thus devoid of any
contamination with bLf monomer and other low molecular weight
whey proteins such as lysozyme (14.6 kDa), a-lactalbumin -
14.12(kDa), b-lactoglobulin – (22.40 kDa), as1-casein –
(33.30 kDa), b-casein – (37.50 kDa). The discovery of functionally
bioactive HMW-bLf in this study has opened up greater scope for
future research, considering the inherent multifunctional nature of
bLf with its potential in improving human health. Through
preclinical and clinical studies, we and others have shown that
NM-bLf and Fe-bLf can not only inhibit tumor development but
also reduce growth and metastasis of solid tumors [5,6,16].
Because of its widely reported multifunctional properties, and
approval by FDA (US) and European Food Safety Authority as a
dietary supplement in food products [38,39] NM-bLf is gaining
recent attention as an important therapeutic and nutraceutical
against cancer, chronic inflammatory, viral and microbial diseases.
In this regard, further studies are therefore, needed to decipher the
structural and functional nature of HMW-bLf with more powerful
techniques for its in-depth molecular organization and biophysical
characterization. This will lead to the identification of similarities
and differences in the activities displayed by these two forms of
bLf, and help in understanding the true potential bLf as a
multifunctional bio-macromolecule, in meeting the aims of
modern medicine.
Supporting Information
File S1 Figures S1–S4. Figure S1. Representative microscopy
images showing trypan blue exclusion assay when the cells were
grown in their respective growth media with 1% FBS for 24 h,
indicating the .98% viability. This indicates that serum
deprivation on incubation with bLf treatments for cellular uptake
Figure 5. Cellular uptake of HMW-bLf. A – Representative confocal microscopic images show HMW-bLf internalization in MDA-MB-231 and
SW480 in a time dependent manner. The degradation of actin an indicator of apoptosis was observed after 6 h of treatment with HMW-bLf. The
reduction in the intensity of the Alexa 568 signal indicates the degradation of the actin cytoskeleton. B and C are high magnification images HMW-bLf
internalization in SW480 (B) and MDA-MB231(C) with separate panels showing nucleus, actin and HMW-bLf alone. Arrows in 4B points out to the cells
that have taken up HMW-bLf showing perturbed actin structure, and arrowhead points out to the cell with intact actin structure and is without HMW-
bLf uptake in 4 h (SW480). Arrows in 4C point out to the beginning of nuclear degradation at 6 h (MDA-MB-231).
doi:10.1371/journal.pone.0106568.g005
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in 1% FBS containing assay media does not compromise the
ability of the cells to exclude the dye and they remained healthy
with intact membranes for cellular uptake of bLf. Magnifications
40X. Figure S2. Representative graph of the percentage iron
content in the different forms of bLf. Figure S3. High resolution
graph of FTIR spectra. The Fe-O vibration band appears at
560 cm-1 in the FTIR spectrum of Fe-bLf, and it is not
pronounced in the other three spectra suggesting the high iron
content in Fe-bLf and confirming iron content estimation. Figure
S4. Cell death (mortality count) in FHs 74 Int as measured by
Flow cytometry using propidium iodide staining (* p,0.05). Fe-
bLf was used as a control. Figure S5: Confocal microscopy images
showing FHs 74 Int cells (of normal intestinal origin) also take up
HMW-bLf in a time dependent fashion. The internalized HMW-
bLf was detected by indirect immunofluorescence using goat anti-
bovine lactoferrin (Bethyl Laboratories) antibody at a dilution of
1:200 in PBS at 37uC for 1 h. The primary antibody was then
removed and after washing, cells were incubated with anti-goat
IgG-FITC conjugate (Sigma-Aldrich) and counterstained for
nucleus with DAPI (blue) in fluorshield (Sigma-Aldrich). Scale
bar = 25 mm.
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Figure 6. Caspase-3 activation. A and B represent the increased caspase-3 activity measurements upon treatment with HMW-bLf in MDA-MB-231
and SW480 cells, respectively. (* P,0.05 and ** P,0.01). Panels C and D are the respective Western blots showing an increase in cleaved caspase-3
expression upon treatments in MDA-MB-231 and SW480 cells.
doi:10.1371/journal.pone.0106568.g006
High Molecular Weight Lactoferrin Targets Cancer Cell Apoptosis
PLOS ONE | www.plosone.org 12 September 2014 | Volume 9 | Issue 9 | e106568
References
1. Kanwar RK, Kanwar JR (2013) Immunomodulatory lactoferrin in the
regulation of apoptosis modulatory proteins in cancer. Protein Pept Lett 20:
450–458.
2. Baker EN, Baker HM (2005) Molecular structure, binding properties and
dynamics of lactoferrin. Cell Mol Life Sci 62: 2531–2539.
3. Gutteridge JM, Paterson SK, Segal AW, Halliwell B (1981) Inhibition of lipid
peroxidation by the iron-binding protein lactoferrin. Biochem J 199: 259.
4. Tomita M, Wakabayashi H, Shin K, Yamauchi K, Yaeshima T, et al. (2009)
Twenty-five years of research on bovine lactoferrin applications. Biochimie 91:
52–57.
5. Kanwar JR, Mahidhara G, Kanwar RK (2012) Novel alginate-enclosed
chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocar-
riers for oral delivery in colon cancer therapy. Nanomedicine 7: 1521–1550.
6. Tsuda H, Kozu T, Iinuma G, Ohashi Y, Saito Y, et al. (2010) Cancer prevention
by bovine lactoferrin: from animal studies to human trial. Biometals 23: 399–
409.
7. Gibbons JA, Kanwar RK, Kanwar JR (2011) Lactoferrin and cancer in different
cancer models. Front biosci (Scholar edition) 3: 1080.
8. Stelwagen K, Carpenter E, Haigh B, Hodgkinson A, Wheeler T (2009) Immune
components of bovine colostrum and milk. J Anim Sci 87: 3–9.
9. Kanyshkova T, Buneva V, Nevinsky G (2001) Lactoferrin and its biological
functions. Biochemistry (Moscow) 66: 1–7.
10. Mantel C, Miyazawa K, Broxmeyer HE (1994) Physical characteristics and
polymerization during iron saturation of lactoferrin, a myelopoietic regulatory
molecule with suppressor activity. Lactoferrin: Springer. pp. 121–132.
11. Nevinskii AG, Soboleva SE, Tuzikov FV, Buneva VN, Nevinsky GA (2009)
DNA, oligosaccharides, and mononucleotides stimulate oligomerization of
human lactoferrin. J Mol Recognit 22: 330–342.
12. Wang H, Hurley WL (1998) Identification of lactoferrin complexes in bovine
mammary secretions during mammary gland involution. J Dairy Sci 81: 1896–
1903.
13. Brisson G, Britten M, Pouliot Y (2007) Heat-induced aggregation of bovine
lactoferrin at neutral pH: Effect of iron saturation. Int Dairy J 17: 617–624.
14. Kanwar JR, Kanwar RK (2009) Gut health immunomodulatory and anti-
inflammatory functions of gut enzyme digested high protein micro-nutrient
dietary supplement-Enprocal. BMC immunol 10: 7.
15. Van Berkel P, Geerts M, Van Veen H, Kooiman P, Pieper F, et al. (1995)
Glycosylated and unglycosylated human lactoferrins both bind iron and show
identical affinities towards human lysozyme and bacterial lipopolysaccharide,
but differ in their susceptibilities towards tryptic proteolysis. Biochem J 312:
107–114.
16. Kanwar JR, Palmano KP, Sun X, Kanwar RK, Gupta R, et al. (2008) ‘Iron-
saturated’lactoferrin is a potent natural adjuvant for augmenting cancer
chemotherapy. Immunol cell biol 86: 277–288.
17. Fujie Y, Yamamoto H, Ngan CY, Takagi A, Hayashi T, et al. (2005)
Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis
and mitotic catastrophe in colon cancer cells. JPN J Clin Oncol 35: 453–463.
18. Sato K, Shiba M, Shigematsu A, Teduka N, Tomizawa A (2004) Method for
producing lactoferrin. Google Patents.
19. Harmon RJ, Schanbacher FL, Ferguson LC, Smith KL (1976) Changes in
lactoferrin, immunoglobulin G, bovine serum albumin, and alpha-lactalbumin
during acute experimental and natural coliform mastitis in cows. Infect Immun
13: 533–542.
20. Castellino FJ, Fish WW, Mann KG (1970) Structural studies on bovine
lactoferrin. J Biol Chem 245: 4269–4275.
21. Persson BA, Lund M, Forsman J, Chatterton DE, Akesson T (2010) Molecular
evidence of stereo-specific lactoferrin dimers in solution. Biophys Chem 151:
187–189.
22. F.L. Schanbacher KLS, Ferguson LC (1971) The similarity of bovine lactoferrin
dimer to IgG2. Fed Proc, 30: p. 532.
23. Bennett RM, Bagby GC, Davis J (1981) Calcium-dependent polymerization of
lactoferrin. Biochem biophys res comm 101: 88–95.
24. Klimesˇ J, Jagosˇ P, Bouda J, Gajdu˚sˇek S (1986) Basic qualitative parameters of
cow colostrum and their dependence on season and post partum time. Acta
Veterinaria Brno 55: 23–39.
25. Sanchez L, Aranda P, Perez MD, Calvo M (1988) Concentration of lactoferrin
and transferrin throughout lactation in cow’s colostrum and milk. Biol Chem
Hoppe Seyler 369: 1005–1008.
26. Soboleva S, Tuzikov F, Tuzikova N, Buneva V, Nevinsky G (2009) DNA and
oligosaccharides stimulate oligomerization of human milk lactoferrin. Mol Biol
43: 142–149.
27. DEPT. OF HEALTH E, AND WELFARE PUBLIC HEALTH SERVICE
FOOD AND DRUG ADMINISTRATION *ORA/ORO/DEIO/IB* (1985)
Inspection Technical Guides, Bacterial Endotoxins/Pyrogens.
28. Xavier PL, Chaudhari K, Verma PK, Pal SK, Pradeep T (2010) Luminescent
quantum clusters of gold in transferrin family protein, lactoferrin exhibiting
FRET. Nanoscale 2: 2769–2776.
29. Kussendrager K (1994) Effects of heat treatment on structure and iron-binding
capacity of bovine lactoferrin. FIL-IDF. Secretariat general.
30. Conesa C, Sa´nchez L, Pe´rez M-D, Calvo M (2007) A calorimetric study of
thermal denaturation of recombinant human lactoferrin from rice. J Agr Food
Chem 55: 4848–4853.
31. Ru¨egg M, Moor U, Blanc B (1977) A calorimetric study of the thermal
denaturation of whey proteins in simulated milk ultrafiltrate. J Dairy Res 44:
509–520.
32. Baker HM, Baker EN (2004) Lactoferrin and iron: structural and dynamic
aspects of binding and release. Biometals 17: 209–216.
33. Troost FJ, Steijns J, Saris WH, Brummer RJ (2001) Gastric digestion of bovine
lactoferrin in vivo in adults. J Nutr 131: 2101–2104.
34. Sitaram MP, McAbee DD (1997) Isolated rat hepatocytes differentially bind and
internalize bovine lactoferrin N- and C-lobes. Biochem J 323 (Pt 3): 815–822.
35. Roseanu A, Florian PE, Moisei M, Sima LE, Evans RW, et al. (2010)
Liposomalization of lactoferrin enhanced its anti-tumoral effects on melanoma
cells. Biometals 23: 485–492.
36. Duarte D, Nicolau A, Teixeira J, Rodrigues L (2011) The effect of bovine milk
lactoferrin on human breast cancer cell lines. J Dairy Sci 94: 66–76.
37. Iigo M, Kuhara T, Ushida Y, Sekine K, Moore MA, et al. (1999) Inhibitory
effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin
Exp Metastasis 17: 35–40.
38. Rulis AM (2001) Agency Response Letter GRAS Notice No. GRN 000077.
39. EFSA Panel on Dietetic Products NaAN (2012) Scientific Opinion on bovine
lactoferrin. EFSA Journal 10(7):2811 [14 pp.].
40. Smith SM, Wunder MB, Norris DA, Shellman YG (2011) A Simple Protocol for
Using a LDH-Based Cytotoxicity Assay to Assess the Effects of Death and
Growth Inhibition at the Same Time. PLoS ONE 6: e26908.
41. Lonnerdal B, Jiang R, Du X (2011) Bovine lactoferrin can be taken up by the
human intestinal lactoferrin receptor and exert bioactivities. J Pediatr Gastro-
enterol Nutr 53: 606–614.
42. Samarasinghe RM, Kanwar RK, Kanwar JR (2014) The effect of oral
administration of iron saturated-bovine lactoferrin encapsulated chitosan-
nanocarriers on osteoarthritis. Biomaterials 35: 7522–7534.
43. Kanwar JR, Mahidhara G, Roy K, Sasidharan S, Krishnakumar S, et al. (2014)
Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and
maintains absorption of iron, calcium and zinc. Nanomedicine: 1–21.
44. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, et al. (1997) Caspase-3–
generated fragment of gelsolin: effector of morphological change in apoptosis.
Science 278: 294–298.
45. Wolf BB, Schuler M, Echeverri F, Green DR (1999) Caspase-3 is the primary
activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/
inhibitor of caspase-activated DNase inactivation. J Biol Chem 274: 30651–
30656.
46. Fleet JC (1995) A New Role for Lactoferrin: DNA Binding and Transcription
Activation. Nutrition Reviews 53: 226–227.
47. Jiang R, Lonnerdal B (2011) Apo-lactoferrin regulates transcription of the TGF
beta 1 gene and may thus stimulate intestinal differentiation. The FASEB
Journal 25: 340.346.
High Molecular Weight Lactoferrin Targets Cancer Cell Apoptosis
PLOS ONE | www.plosone.org 13 September 2014 | Volume 9 | Issue 9 | e106568
